This hypothesis could be tested in glioblastoma, stomach, and esophageal cancer cell lines by determining whether they express NAGS, CPS1, and/or citrin genes and proteins, followed by measuring the rate of cell proliferation and metabolite concentrations after knocking down the expression of the three genes. Here, NAGS is linked to esophageal cancer.